Ascendis Pharma Oncology Division A/s

This study tested an experimental drug called TransCon TLR7/8 Agonist, given as an injection into tumors, either alone or with another drug (pembrolizumab). It aimed to find a safe dose and check for side effects in people with advanced solid tumors that had stopped responding to…